Your browser doesn't support javascript.
loading
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.
Nast, Alexander; Amelunxen, Lasse; Augustin, Matthias; Boehncke, Wolf-Henning; Dressler, Corinna; Gaskins, Matthew; Härle, Peter; Hoffstadt, Bernd; Klaus, Joachim; Koza, Joachim; Mrowietz, Ulrich; Ockenfels, Hans-Michael; Philipp, Sandra; Reich, Kristian; Rosenbach, Thomas; Rzany, Berthold; Schlaeger, Martin; Schmid-Ott, Gerhard; Sebastian, Michael; von Kiedrowski, Ralph; Weberschock, Tobias.
Afiliação
  • Nast A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM).
  • Amelunxen L; Fachklinik Bad Bentheim [Bad Bentheim Specialist Hospital].
  • Augustin M; Universitätsklinikum Hamburg-Eppendorf, Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen [University Hospital Hamburg-Eppendorf, Institute for Health Care Research in Dermatology and Nursing].
  • Boehncke WH; Service de Dermatologie et Vénéréologie, Hôpitaux Universitaires de Genève [Dermatology and Venereology Service, Geneva University Hospitals].
  • Dressler C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM).
  • Gaskins M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM).
  • Härle P; Katholisches Klinikum Mainz, Zentrum für Rheumatologische Akutdiagnostik, Klinik für Rheumatologie, Klinische Immunologie und Physikalische Therapie [Catholic Medical Center Mainz, Center for Rheumatological Diagnostics, Department of Rheumatology, ClinicaI Immunology and Physical Therapy].
  • Hoffstadt B; Selbsthilfegemeinschaft Haut e. V. [Skin self-help association].
  • Klaus J; Deutscher Psoriasis Bund e. V. [German Psoriasis Society].
  • Koza J; Deutscher Psoriasis Bund e. V. [German Psoriasis Society].
  • Mrowietz U; Psoriasis-Zentrum, Klinik für Dermatologie, Venerologie, Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel [Psoriasis Center, Department of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein Kiel campus].
  • Ockenfels HM; Haut- und Allergieklinik, Klinikum Hanau [Department of Dermatology and Allergology, Hanau Medical Center].
  • Philipp S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Psoriasisstudienzentrum [Psoriasis Study Center].
  • Reich K; Dermatologikum Hamburg [Dermatologikum Hamburg].
  • Rosenbach T; Niedergelassener Dermatologe, Osnabrück [Office-based Dermatologist, Osnabrück].
  • Rzany B; Privatpraxis Rzany & Hund, Berlin [Office-based Dermatologists Rzany & Hund, Berlin].
  • Schlaeger M; Niedergelassener Dermatologe, Oldenburg [Office-based Dermatologist, Osnabrück].
  • Schmid-Ott G; Berolina Klinik, Löhne [Berolina Medical Center, Löhne].
  • Sebastian M; Niedergelassener Dermatologe, Mahlow [Office-based Dermatologist, Mahlow].
  • von Kiedrowski R; Niedergelassener Dermatologe, Selters [Office-based Dermatologist, Selters].
  • Weberschock T; Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Frankfurt, Frankfurt/Main und Arbeitsgruppe EbM Frankfurt, Institut für Allgemeinmedizin, Goethe-Universität Frankfurt, Frankfurt/Main [Department of Dermatology, Venereology and Allergology, Frankfurt University Hospital, F
J Dtsch Dermatol Ges ; 16(5): 645-669, 2018 May.
Article em En | MEDLINE | ID: mdl-29750443
ABSTRACT
The German guideline for the treatment of psoriasis vulgaris was updated using GRADE methodology. The guideline is based on a systematic literature review completed on December 1, 2016, and on a formal consensus and approval process. The first section of this short version of the guideline covers systemic treatment options considered relevant by the expert panel and approved in Germany at the time of the consensus conference (acitretin, adalimumab, apremilast, cyclosporine, etanercept, fumaric acid esters, infliximab, methotrexate, secukinumab and ustekinumab). Detailed information is provided on the management and monitoring of the included treatment options.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article